<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zagouri, F.</style></author><author><style face="normal" font="default" size="100%">Sergentanis, T.N.</style></author><author><style face="normal" font="default" size="100%">Gazouli, M.</style></author><author><style face="normal" font="default" size="100%">Dimitrakakis, C.</style></author><author><style face="normal" font="default" size="100%">Tsigginou, A.</style></author><author><style face="normal" font="default" size="100%">Papaspyrou, I.</style></author><author><style face="normal" font="default" size="100%">Chrysikos, D.</style></author><author><style face="normal" font="default" size="100%">Lymperi, M.</style></author><author><style face="normal" font="default" size="100%">Zografos, G.C.</style></author><author><style face="normal" font="default" size="100%">Antsaklis, A.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, M.-A.</style></author><author><style face="normal" font="default" size="100%">Papadimitriou, C.A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">MMP-2 -1306C &gt; T polymorphism in breast cancer: A case-control study in a South European population</style></title><secondary-title><style face="normal" font="default" size="100%">Molecular Biology Reports</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">breast cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Case control</style></keyword><keyword><style  face="normal" font="default" size="100%">MMP-2</style></keyword><keyword><style  face="normal" font="default" size="100%">MMP-2 -1306C &gt; T polymorphism</style></keyword><keyword><style  face="normal" font="default" size="100%">Polymorphism</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881124597&amp;doi=10.1007%2fs11033-013-2604-5&amp;partnerID=40&amp;md5=f3a91b39f25445a1e4243dbd725f517a</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">40</style></volume><pages><style face="normal" font="default" size="100%">5035 - 5040</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">This case control study aims to investigate the role of MMP-2 -1306C &gt; T polymorphism as a potential risk factor and possible prognostic marker for breast cancer in a South European population. 113 consecutive incident cases of histologically confirmed ductal breast cancer and 124 healthy controls were recruited. MMP-2 -1306C &gt; T polymorphism was genotyped; multivariate logistic regression as well as Cox regression analysis were performed. MMP-2 -1306C &gt; T status was not associated with breast cancer risk either at the total sample or at the subanalyses on premenopausal and postmenopausal women. At the survival analysis, a trend towards a favorable association between MMP-2 -1306C &gt; T allele and disease-free survival as well as overall survival was observed. Regarding subanalyses on ER-negative and ER-positive cases, the favorable association implicating MMP-2 -1306C &gt; T allele was particularly evident among ER-positive cases; no significant associations emerged among ER-negative cases. MMP-2 -1306C &gt; T polymorphism does not seem to be a risk factor for breast cancer in South European population; however, a trend towards a favorable association with survival has been observed. © 2013 Springer Science+Business Media Dordrecht.</style></abstract><issue><style face="normal" font="default" size="100%">8</style></issue><notes><style face="normal" font="default" size="100%">Cited By :2Export Date: 21 February 2017</style></notes></record></records></xml>